Mechanistische Analysen zu Krankheits-korrelierten SNPs in ...

7 Literaturverzeichnis
[146] MARTIN, M. M. ; BUCKENBERGER, J. A. ; JIANG, J. ; MALANA, G. E. ; NUOVO, G. J. ; CHOTANI,
M. ; FELDMAN, D. S. ; SCHMITTGEN, T. D. ; ELTON, T. S.: The human angiotensin II type
1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. In: J Biol Chem 282
(2007), S. 24262–9
[147] SETHUPATHY, P. ; BOREL, C. ; GAGNEBIN, M. ; GRANT, G. R. ; DEUTSCH, S. ; ELTON, T. S.
; HATZIGEORGIOU, A. G. ; ANTONARAKIS, S. E.: Human microRNA-155 on chromosome 21
differentially interacts with its polymorphic target in the AGTR1 3’ untranslated region: a mechanism
for functional single-nucleotide polymorphisms related to phenotypes. In: Am J Hum
Genet 81 (2007), S. 405–13
[148] ADAMS, B. D. ; FURNEAUX, H. ; WHITE, B. A.: The micro-ribonucleic acid (miRNA) miR-206
targets the human estrogen receptor-alpha (ERalpha) and represses ERalpha messenger RNA
and protein expression in breast cancer cell lines. In: Mol Endocrinol 21 (2007), S. 1132–47
[149] MISHRA, P. J. ; HUMENIUK, R. ; LONGO-SORBELLO, G. S. ; BANERJEE, D. ; BERTINO, J. R.:
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate
resistance. In: Proc Natl Acad Sci U S A 104 (2007), S. 13513–8
[150] BAUDIN, B.: Polymorphism in angiotensin II receptor genes and hypertension. In: Exp Physiol
90 (2005), S. 277–282
[151] ORO, C. ; QIAN, H. ; THOMAS, W. G.: Type 1 angiotensin receptor pharmacology: signaling
beyond G proteins. In: Pharmacol Ther 113 (2007), S. 210–226
[152] ROSSKOPF, D. ; MICHEL, M. C.: Pharmacogenomics of G protein-coupled receptor ligands in
cardiovascular medicine. In: Pharmacol Rev 60 (2008), S. 513–535
[153] BONNARDEAUX, A. ; DAVIES, E. ; JEUNEMAITRE, X. ; FÉRY, I. ; CHARRU, A. ; CLAUSER, E.
; TIRET, L. ; CAMBIEN, F. ; CORVOL, P. ; SOUBRIER, F.: Angiotensin II type 1 receptor gene
polymorphisms in human essential hypertension. In: Hypertension 24 (1994), S. 63–69
[154] TSIAMBAS, E. ; GEORGIANNOS, S. N. ; SALEMIS, N. ; ALEXOPOULOU, D. ; LAMBROPOULOU,
S. ; DIMO, B. ; IOANNIDIS, I. ; KRAVVARITIS, C. ; KARAMERIS, A. ; PATSOURIS, E. ; DOURAKIS,
S.: Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular
carcinomas based on tissue microarrays analysis. In: Med Oncol 28 (2011), S. 934–940
[155] SHIMIZU, I.: Impact of oestrogens on the progression of liver disease. In: Liver Int 23 (2003),
S. 63–69
[156] CHANG, J. ; NICOLAS, E. ; MARKS, D. ; SANDER, C. ; LERRO, A. ; BUENDIA, M. A. ; XU, C.
; MASON, W. S. ; MOLOSHOK, T. ; BORT, R. ; ZARET, K. S. ; TAYLOR, J. M.: miR-122, a
mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the
high affinity cationic amino acid transporter CAT-1. In: RNA Biol 1 (2004), S. 106–113
[157] LAGOS-QUINTANA, M. ; RAUHUT, R. ; YALCIN, A. ; MEYER, J. ; LENDECKEL, W. ; TUSCHL, T.:
Identification of tissue-specific microRNAs from mouse. In: Curr Biol 12 (2002), S. 735–739
[158] IKEDA, S. ; PU, W. T.: Expression and function of microRNAs in heart disease. In: Curr Drug
Targets 11 (2010), S. 913–25
[159] VAN ROOIJ, E. ; SUTHERLAND, L. B. ; LIU, N. ; WILLIAMS, A. H. ; MCANALLY, J. ; GERARD, R. D.
; RICHARDSON, J. A. ; OLSON, E. N.: A signature pattern of stress-responsive microRNAs that
can evoke cardiac hypertrophy and heart failure. In: Proc Natl Acad Sci U S A 103 (2006), S.
18255–18260
[160] SOBER, S. ; LAAN, M. ; ANNILO, T.: MicroRNAs miR-124 and miR-135a are potential regulators
of the mineralocorticoid receptor gene (NR3C2) expression. In: Biochem Biophys Res Commun
391 (2010), S. 727–32
[161] GOTO, Y. ; YUE, L. ; YOKOI, A. ; NISHIMURA, R. ; UEHARA, T. ; KOIZUMI, S. ; SAIKAWA, Y.: A
162